Albert and Jakobiec's Principles and Practice of Ophthalmology

Keeping up to date with advances in comprehensive ophthalmology and in the ophthalmic sub-specialties is extremely difficult because of the accelerating rapidity with which new information and technology become available and the diminishing time and opportunity for practitioners and trainees to read and learn. The first edition of Albert and Jakobiec’s Principles and Practice (1994) was conceived with the idea of utilizing an electronic, updated version in which the chapters were revised by the chapter authors on an annual or semi-annual basis, but the technology was not sufficiently advanced to achieve this goal. Subsequent editions (2000 and 2008) were organized by Saunders and the last published by Elsevier (of which Springer has obtained the complete rights to move forward with the 4^th edition). 

For nearly three decades, this text has provided its readers with authoritative and comprehensive coverage of clinical ophthalmology, written and edited by a group of authors who represented a “Who’s Who” in ophthalmology. By using Springer’s Meteor platform, with its ability to allow authors and editors access to updating their chapters online annually/semi-annually, and with the recruitment of select chapter authors, this work’s usefulness as the standard text in ophthalmology will be maintained and expanded upon by Springer. 

The 4^th edition of this comprehensive and authoritative text is written by hundreds of the most distinguished authorities from around the world and edited by four leaders in the field, providing today's best answers to every question that arises in ophthalmology practice. Richly illustrated with thousands of high quality, full color, clinically-relevant images, Albert and Jakobiec's Principles and Practice of Ophthalmology, 4th Edition covers every scientific and clinical principle in ophthalmology, ensuring that the reader will always be able to find the guidance needed to diagnose and manage patients' ocular problems and meet today's standards of care. Written for practicing ophthalmologists and trainees,  this book delivers in-depth guidance on new diagnostic approaches, operative techniques, and treatment options, as well as coherent explanations of new scientific concept and its clinical importance. The 4^th edition will prove to be the source every practicing clinician needs to efficiently and confidently overcome any clinical challenge they may face. 

Updates include new chapters on anterior and posterior segment diseases, as well as chapters more focused on treatment, plus thousands of new, high-quality, color images and illustrations, updated references, and information on the most cutting-edge technology used by clinicians in their practices today. Additionally, readers will enjoy the same, user-friendly, full-color design they remember from the previous edition, complete with many at-a-glance summary tables, algorithms, boxes, and diagrams that allow the reader to locate the assistance needed more rapidly than ever. 

Dr Daniel M. Albert began his academic career at Yale University and continued at Harvard University and the Massachusetts Eye and Ear Infirmary. He moved to the University of Wisconsin-Madison in 1992 to become department chair, then chair emeritus of ophthalmology and visual sciences, the Frederick Allison Davis Chair; the Lorenz Zimmerman Professor; and founding director of the McPherson Eye Research Institute. Dr. Albert is now a researcher for Oregon Health & Science University and his research focuses on the treatment and prevention of ocular cancers; particularly the use of vitamin D analogues, resveratrol and its analogues, and anti-angiogenic peptides in the treatment and prevention of ocular cancer and in reversing angiogenesis in the wet form of macular degeneration.

Joan W. Miller is Chief and Chair in the Department of Ophthalmology at Massachusetts Eye and Ear and is an internationally recognized expert on retinal disorders. As a vitreoretinal physician in Mass. Eye and Ear's Retina Service, she treats patients with age-related macular degeneration (AMD), retinal degenerations, and diabetic retinopathy. 

Dr. Miller received her medical degree and ophthalmology residency training from Harvard Medical School and then completed fellowships in ophthalmology research and vitreoretinal surgery at Mass. Eye and Ear. Dr. Miller is the first female physician to achieve the rank of Professor of Ophthalmology at Harvard Medical School and the first woman to chair the Department of Ophthalmology. She is also the first woman appointed as Chief of Ophthalmology at both Mass. Eye and Ear and Massachusetts General Hospital. In addition to these roles and responsibilities, she also co-directs Mass. Eye and Ear's Angiogenesis Laboratory. 

Dr. Miller, along with Dr. Evangelos Gragoudas, are credited with developing photodynamic therapy with verteporfin (Visudyne®). This therapy was the first AMD treatment approved by the U.S. Food and Drug Administration and drug regulatory agencies worldwide. In addition, Dr. Miller is recognized for co-discovering the role of vascular endothelial growth factor (VEGF) in eye disease and demonstrating the therapeutic potential of VEGF inhibitors. This work formed the scientific basis of anti-angiogenic ophthalmic therapies, which are widely used to prevent vision loss in AMD and other retinal diseases by blocking abnormal blood vessel growth and leakage. Dr. Miller continues to conduct research to improve therapeutic options for retinal disease. 

Dr. Miller has received numerous prestigious awards. For her contributions to the development of anti-angiogenic retinal therapies, she was a co-recipient of the 2014 Antonio Champalimaud Vision Award, which is the highest distinction in ophthalmology and visual science. She also was the first woman to receive the Mildred Weisenfeld Award for Excellence in Ophthalmology. 

Dimitri Azar, MD, MBA is Dean in the College of Medicine at the University of Illinois and is Professor of Ophthalmology, Bioengineering and Pharmacology as well as the B.A. Field Chair in Ophthalmologic Research. Dr. Azar is an internationally recognized ophthalmic surgeon who brings experience in administration, research, education and clinical practice to his position as Dean of the College of Medicine at University of Illinois. 

He joined the faculty in 2006 as Head of the Department of Ophthalmology & Visual Sciences. Previously he was a tenured Professor of Ophthalmology at Harvard Medical School, Director of the Cornea Service at Massachusetts Eye and Ear Infirmary, Senior Scientist at Schepens Eye Institute and a faculty member at Johns Hopkins School of Medicine. He is a leader in basic science and clinically related vision research, making significant contributions to the treatment of corneal diseases and to advances in refractive surgery through mathematical analyses and applications of advanced optics. His basic science research on matrix metalloproteinases in corneal wound healing and angiogenesis has been continually funded by the National Eye Institute R01 award since 1993. 

Dr. Azar is the author of more than 400 scientific articles and book chapters. He is the editor of 14 books in ophthalmology and holds 15 patents. He has been named one of The Best Doctors in America or recognized among Castle Connolly’s Regional Top Doctors in America annually since 1994. He serves as a trustee for the Chicago Ophthalmological Society and for the Association of Research and Vision in Ophthalmology. Dr. Azar has received multiple leadership awards, including the 2009 Lans Distinguished Award and the University of Illinois at Chicago Scholar Award.

Lucy Hwa-Yue Young, MD, PhD, FACS, is a multilingual vitreoretinal surgeon at Massachusetts Eye and Ear and associate professor of ophthalmology at Harvard Medical School. Dr. Young spent her childhood in Taiwan and Brazil before relocating to the United States, becoming fluent in English as well as Mandarin Chinese, Portuguese, and Spanish. She received her B.S. in molecular biology and M.D. from University of Wisconsin-Madison, then continued her training at Harvard University, where she earned her M.A. and Ph.D. degrees in biology. She conducted her ophthalmology residency and vitreoretinal fellowship at Massachusetts Eye and Ear, Harvard Medical School. Dr. Young’s clinical and research interests encompass numerous vitreoretinal conditions, including trauma-related complications, infectious retinitis (particularly AIDS-related retinal infections), diabetic retinopathy, and macular degeneration. As a senior scientist at Massachusetts Eye and Ear, she is conducting several lines of investigation to improve the diagnosis and treatment of ocular toxoplasmosis. Dr. Young has co-authored more than 100 peer-reviewed research articles, reviews, and book chapters, and has been a member of the investigative team for more than 25 clinical trial reports. Ophthalmology education is also a major focus of Dr. Young’s activities where she serves as director of the Altschuler Ophthalmology Surgical Training Laboratory—a state-of-the-art training facility established in honor of Dr. Young. She also directs the Lancaster Course in Ophthalmology, which is based at Colby College in Waterville, Maine, and draws ophthalmology practitioners and trainees internationally. In addition to excellence in teaching, mentoring, and research, Dr. Young is recognized in Castle Connolly’s Top Doctors since 2008 and Boston Magazine’s Top Doctors since 2017.